Effects of low-dose metformin in Japanese women with clomiphene-resistant polycystic ovary syndrome

Reproductive Medicine and Biology

Volumn 3, Issue 1, 2004, Pages 19-26

  Kurabayashi, Takumi ^a,b   Suzuki, Mina ^a   Kashima, Katsunori ^a   Banzai, Junichi ^a   Terabayashi, Kyoko ^a   Fujita, Kazuyuki ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Clomiphene; Insulin resistance; Metformin; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GESTAGEN; GLUCOSE; HEMOGLOBIN A1C; HYDROXYPROGESTERONE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; METFORMIN; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG EFFECT; DRUG MECHANISM; EMBRYO TRANSFER; ENZYME IMMUNOASSAY; FEMALE; FERTILIZATION IN VITRO; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPAN; LOW DRUG DOSE; NAUSEA; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; VOMITING; WITHDRAWAL BLEEDING;

EID: 20444393499     PISSN: 14455781     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0578.2004.00047.x     Document Type: Article

References (31)

1. Frank S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
2. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med 1995; 98: 33S-39S.
3. Kiddy DS, Hamilton-Fairley D, Bush A et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105-111.
4. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-1880.
5. Hasegawa I, Murakawa H, Suzuki M, Yamamoto Y, Kurabayashi T, Tanaka K. Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. Fertil Steril 1999; 71: 323-327.
6. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz MJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 209-215.
7. Seli E, Duleba AJ. Optimizing ovulation induction in women with polycystic ovary syndrome. Curr Opin Obstet Gynaecol 2000; 14: 245-254.
8. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335:617-623.
9. Acbay O, Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 1996; 65: 946-949.
10. Ehrmann DA, Cavaghan MK, Imperial J, Sturis J, Rosenfield RL, Polonsky KS. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 524-530.
11. The ESHRE Capri Workshop. Female infertility: treatment options for complicated cases. Hum Reprod 1997; 12: 1191-1196.
12. Murakawa H, Hasegawa I, Kurabayashi T, Tanaka K. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med 1999; 44: 23-27.
13. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-2698.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Vandermolen DT, Ratts VS, Evans WS, Stovall D, Kauma SW, Nestler JE. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertile Steril 2001; 75: 310-315.
16. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, an pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002; 77: 101-106.
17. Ng EH, Wat NM, Ho PC. Effects of metformin on ovulation rate, hormonal and metabolic profile in women with clomiphene-resistant polycystic ovaries: a randomized double-blinded placebo-controlled trial. Hum Reprod 2001; 16: 1625-1631.
18. Mitwally MFM, Kuscu NK, Yalcinkaya TM. High ovulatory rates with the use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome. Hum Reprod 1999; 14: 2700-2703.
19. Castello MF, Eden JA. A systemic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003; 79: 1-13.
20. Moghetti P, Castello R, Negri C et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 139-146.
21. Ciampelli M, Guido M, Cucinelli F, Cinque B, Barini A, Lanzone A. Hypothalomic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome. Fertil Steril 2000; 73: 712-717.
22. Sengos C, Andreakos C, Latrakis G. Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome. Clin Exp Obstet Gynecol 2000; 27: 35-38.
23. George SS, George K, Irwin C et al. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome; a randomized, controlled trial. Hum Reprod 2003; 18: 299-304.
24. Franks S, Gharani N, Waterworth D et al. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997; 12: 2641-2648.
25. De Leo V, Marca A, Ditto A, Morgante G, Cianci A. Effects of metformin on gonadotropin induce ovulation in women with polycystic ovary syndrome. Fertil Steril 1999; 72: 282-285.
26. Futterweit W. Polycystic ovary syndrome: clinical perspectives and management. Obstet Gynecol Surv 1999; 54: 403-413.
27. Legro RS, Kunselma AR, Dodson WC, Dunaif A. Prevalence and predictor of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome A prospective controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165-169.
28. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictor of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001; 111: 607-613.
29. Paradisi G, Steinberg HO, Hempfling A et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001; 103: 1410-1415.
30. Ibanez L, Valls C, Ferrer A, Ong K, Dunger DB, Zegher F. Additive effects of insulin-sensitizing and anti-androgen treatment in young non-obese women with hyperinsulinism, hyperandrogenism dyslipidemia, and anovulation. J Clin Endocrinol Metab 2002; 87: 2870-2874.
31. Kurabayashi T, Kase H, Suzuki M, Sugaya S, Fujita K, Tanaka K. The behavior of endometrial abnormalities in infertility patients. J Reprod Med 2003; 48: 455-459.